
Serac Healthcare has presented phase 2 data suggesting its investigational imaging agent, 99mTc-maraciclatide, may help distinguish active inflammation from fibrosis …
AstraZeneca is stopping two trials of a combination of two of its pipeline cancer treatments, after reports that the pairing …

